Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation.
Saved in:
| Title: | Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation. |
|---|---|
| Authors: | Kyttaris VC; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Petri MA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Wallace DJ; Kao Autoimmunity Center, Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Rogers JL; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Busch H; Florida Arthritis Center-American Arthritis and Rheumatology Associates/Bendcare, Jupiter, Florida, USA., Daniel R; Bay Area Rheumatology, Clearwater, Florida, USA., Concoff A; Exagen, Carlsbad, California, USA., Taghavi S; Exagen, Carlsbad, California, USA., Warsi T; Exagen, Carlsbad, California, USA., Schleif C; Exagen, Carlsbad, California, USA., Alvarez C; Exagen, Carlsbad, California, USA., Partain BD; Exagen, Carlsbad, California, USA., O'Malley T; Exagen, Carlsbad, California, USA tomalley@exagen.com., Mahler M; Exagen, Carlsbad, California, USA. |
| Source: | Lupus science & medicine [Lupus Sci Med] 2026 May 29; Vol. 13 (1). Date of Electronic Publication: 2026 May 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42215053 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kyttaris+VC%22">Kyttaris VC</searchLink>; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Petri+MA%22">Petri MA</searchLink>; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Wallace+DJ%22">Wallace DJ</searchLink>; Kao Autoimmunity Center, Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Rogers+JL%22">Rogers JL</searchLink>; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Busch+H%22">Busch H</searchLink>; Florida Arthritis Center-American Arthritis and Rheumatology Associates/Bendcare, Jupiter, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Daniel+R%22">Daniel R</searchLink>; Bay Area Rheumatology, Clearwater, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Concoff+A%22">Concoff A</searchLink>; Exagen, Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Taghavi+S%22">Taghavi S</searchLink>; Exagen, Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Warsi+T%22">Warsi T</searchLink>; Exagen, Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Schleif+C%22">Schleif C</searchLink>; Exagen, Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Alvarez+C%22">Alvarez C</searchLink>; Exagen, Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Partain+BD%22">Partain BD</searchLink>; Exagen, Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22O'Malley+T%22">O'Malley T</searchLink>; Exagen, Carlsbad, California, USA tomalley@exagen.com.<br /><searchLink fieldCode="AU" term="%22Mahler+M%22">Mahler M</searchLink>; Exagen, Carlsbad, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101633705%22">Lupus science & medicine</searchLink> [Lupus Sci Med] 2026 May 29; Vol. 13 (1). <i>Date of Electronic Publication: </i>2026 May 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ%22">BMJ </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101633705 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2053-8790 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220538790%22">20538790 </searchLink><i>NLM ISO Abbreviation: </i>Lupus Sci Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42215053 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/lupus-2026-002002 Languages: – Code: eng Text: English Titles: – TitleFull: Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kyttaris VC – PersonEntity: Name: NameFull: Petri MA – PersonEntity: Name: NameFull: Wallace DJ – PersonEntity: Name: NameFull: Rogers JL – PersonEntity: Name: NameFull: Busch H – PersonEntity: Name: NameFull: Daniel R – PersonEntity: Name: NameFull: Concoff A – PersonEntity: Name: NameFull: Taghavi S – PersonEntity: Name: NameFull: Warsi T – PersonEntity: Name: NameFull: Schleif C – PersonEntity: Name: NameFull: Alvarez C – PersonEntity: Name: NameFull: Partain BD – PersonEntity: Name: NameFull: O'Malley T – PersonEntity: Name: NameFull: Mahler M IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 05 Text: 2026 May 29 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2053-8790 Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: Lupus science & medicine Type: main |
| ResultId | 1 |